Ann: Half Yearly Report and Accounts, page-100

I’m a big believer in OCC. The last week has rattled me a bit and also the latest financials with a decrease in revenue. OCC have had funds to market sales and increase revenue for already in market products but have seemed to go in reverse. I must admit I wasn’t big fan of their dental application but moore interested in the tendon and nerve. Yes JnJ are doing the study and results are good so far. Still a ways away from brining it to market though and in guessing this is what concerns the market. No for seeable revenue will be generated in the short term and relying on JnJ to rally the SP is not entirely unreliable but still guess work as to the level of commitment. I am still in on though and happy to sit and wait. IMO